Enhancer-dependent 5′-Splice Site Control of fruitless Pre-mRNA Splicing

Bianca J. Lam, Arati Bakshi, F.Y. Ekinci, Jenny Webb, Brenton R. Graveley, Klemens J. Hertel

Journal of Biological Chemistry · 2003 · 36 citations · 50 references

DOIFull text

Open access

Concepts

Abstract

The Drosophila fruitless (fru) gene encodes a transcription factor that essentially regulates all aspects of male courtship behavior. The use of alternative 5′-splice sites generates fru isoforms that determine gender-appropriate sexual behaviors. Alternative splicing of fru is regulated by TRA and TRA2 and depends on an exonic splicing enhancer (fruRE) consisting of three 13-nucleotide repeat elements, nearly identical to those that regulate alternative sex-specific 3′-splice site choice in the doublesex (dsx) gene. dsx has provided a useful model system to investigate the mechanisms of enhancer-dependent 3′-splice site choice. However, little is known about enhancer-dependent regulation of alternative 5′-splice sites. The mechanisms of this process were investigated using an in vitro system in which recombinant TRA/TRA2 could activate the female-specific 5′-splice site of fru. Mutational analysis demonstrated that one 13-nucleotide repeat element within the fruRE is required and sufficient to activate the regulated female-specific splice site. As was established for dsx, the fruRE can be replaced by a short element encompassing tandem 13-nucleotide repeat elements, by heterologous splicing enhancers, and by artificially tethering a splicing activator to the pre-mRNA. Complementation experiments showed that Ser/Arg-rich proteins facilitate enhancer-dependent 5′-splice site activation. We conclude that splicing enhancers function similarly in activating regulated 5′- and 3′-splice sites. These results suggest that exonic splicing enhancers recruit multiple spliceosomal components required for the initial recognition of 5′- and 3′-splice sites. The Drosophila fruitless (fru) gene encodes a transcription factor that essentially regulates all aspects of male courtship behavior. The use of alternative 5′-splice sites generates fru isoforms that determine gender-appropriate sexual behaviors. Alternative splicing of fru is regulated by TRA and TRA2 and depends on an exonic splicing enhancer (fruRE) consisting of three 13-nucleotide repeat elements, nearly identical to those that regulate alternative sex-specific 3′-splice site choice in the doublesex (dsx) gene. dsx has provided a useful model system to investigate the mechanisms of enhancer-dependent 3′-splice site choice. However, little is known about enhancer-dependent regulation of alternative 5′-splice sites. The mechanisms of this process were investigated using an in vitro system in which recombinant TRA/TRA2 could activate the female-specific 5′-splice site of fru. Mutational analysis demonstrated that one 13-nucleotide repeat element within the fruRE is required and sufficient to activate the regulated female-specific splice site. As was established for dsx, the fruRE can be replaced by a short element encompassing tandem 13-nucleotide repeat elements, by heterologous splicing enhancers, and by artificially tethering a splicing activator to the pre-mRNA. Complementation experiments showed that Ser/Arg-rich proteins facilitate enhancer-dependent 5′-splice site activation. We conclude that splicing enhancers function similarly in activating regulated 5′- and 3′-splice sites. These results suggest that exonic splicing enhancers recruit multiple spliceosomal components required for the initial recognition of 5′- and 3′-splice sites. Alternative pre-mRNA splicing is commonly used to regulate the expression of genes and to enrich the proteomic diversity of higher eukaryotic organisms (1Smith C.W. Valcarcel J. Trends Biochem. Sci. 2000; 25: 381-388Abstract Full Text Full Text PDF PubMed Scopus (752) Google Scholar, 2Black D.L. Cell. 2000; 103: 367-370Abstract Full Text Full Text PDF PubMed Scopus (451) Google Scholar, 3Graveley B.R. Trends Genet. 2001; 17: 100-107Abstract Full Text Full Text PDF PubMed Scopus (932) Google Scholar, 4Maniatis T. Tasic B. Nature. 2002; 418: 236-243Crossref PubMed Scopus (598) Google Scholar). Current estimates suggest that ∼60% of human genes are alternatively spliced (5Modrek B. Lee C. Nat. Genet. 2002; 30: 13-19Crossref PubMed Scopus (1045) Google Scholar), sometimes leading to thousands of different mRNA isoforms from a single gene. Numerous examples describe how alternative splicing regulates gene expression in humans, but the mechanisms involved are understood in only a few cases (6Rio D.C. Gene Expr. 1992; 2: 1-5PubMed Google Scholar, 7Horowitz D.S. Krainer A.R. Trends Genet. 1994; 10: 100-106Abstract Full Text PDF PubMed Scopus (212) Google Scholar, 8Black D.L. RNA (N. Y.). 1995; 1: 763-771PubMed Google Scholar, 9Adams M.D. Rudner D.Z. Rio D.C. Curr. Opin. Cell Biol. 1996; 8: 331-339Crossref PubMed Scopus (117) Google Scholar, 10Wang J. Manley J.L. Curr. Opin. Genet. Dev. 1997; 7: 205-211Crossref PubMed Scopus (98) Google Scholar, 11Lopez A.J. Annu. Rev. Genet. 1998; 32: 279-305Crossref PubMed Scopus (535) Google Scholar, 12Stojdl D.F. Bell J.C. Biochem. Cell Biol. 1999; 77: 293-298Crossref PubMed Scopus (81) Google Scholar, 13Chou M.Y. Rooke N. Turck C.W. Black D.L. Mol. Cell. Biol. 1999; 19: 69-77Crossref PubMed Scopus (213) Google Scholar, 14Modafferi E.F. Black D.L. RNA (N. Y.). 1999; 5: 687-706Crossref PubMed Scopus (59) Google Scholar, 15Li X. Shambaugh M.E. Rottman F.M. Bokar J.A. RNA (N. Y.). 2000; 6: 1847-1858Crossref PubMed Scopus (15) Google Scholar, 16Zhu J. Mayeda A. Krainer A.R. Mol. Cell. 2001; 8: 1351-1361Abstract Full Text Full Text PDF PubMed Scopus (291) Google Scholar, 17Expert-Bezancon A. Le Caer J.P. Marie J. J. Biol. Chem. 2002; 277: 16614-16623Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar). In contrast, the use of genetics in Drosophila has aided in the identification of proteins that regulate alternative splicing. In particular, the genes involved in Drosophila sex determination have become prototypes for the study of positive and negative control of alternative splicing (18Baker B.S. Nature. 1989; 340: 521-524Crossref PubMed Scopus (362) Google Scholar). The best characterized gene is the doublesex (dsx) 1The abbreviations used are: dsx, doublesex; TRA, Transformer; TRA2, Transformer2; ESE, exonic splicing enhancer; RS, Arg/Ser-rich; SR, Ser/Arg-rich; dsxRE, dsx splicing enhancer repeat element; snRNP, small nuclear ribonucleoprotein; U2AF, U2 auxiliary factor; ASF, alternative splicing factor; SF2, splicing factor-2; fru, fruitless; fruRE, fru splicing enhancer repeat element; PRE, purine-rich element. 1The abbreviations used are: dsx, doublesex; TRA, Transformer; TRA2, Transformer2; ESE, exonic splicing enhancer; RS, Arg/Ser-rich; SR, Ser/Arg-rich; dsxRE, dsx splicing enhancer repeat element; snRNP, small nuclear ribonucleoprotein; U2AF, U2 auxiliary factor; ASF, alternative splicing factor; SF2, splicing factor-2; fru, fruitless; fruRE, fru splicing enhancer repeat element; PRE, purine-rich element. gene, in which the use of two alternative 3′-splice sites leads to the expression of male- or female-specific gene products that initiate gender-specific sexual differentiation. Female-specific splicing of dsx requires the production of two proteins, Transformer (TRA) and Transformer2 (TRA2), and an exonic splicing enhancer (ESE) element located within the untranslated region of the fourth exon (19McKeown M. Belote J.M. Boggs R.T. Cell. 1988; 53: 887-895Abstract Full Text PDF PubMed Scopus (113) Google Scholar, 20Nagoshi R.N. McKeown M. Burtis K.C. Belote J.M. Baker B.S. Cell. 1988; 53: 229-236Abstract Full Text PDF PubMed Scopus (198) Google Scholar, 21Nagoshi R.N. Baker B.S. Genes Dev. 1990; 4: 89-97Crossref PubMed Scopus (109) Google Scholar). Both TRA and TRA2 contain Arg/Ser-rich (RS) domains, protein interaction domains characteristic of the Ser/Arg-rich (SR) family of essential splicing factors. SR proteins are thought to function by binding to ESEs and by recruiting the splicing machinery to adjacent introns via protein interactions involving the RS domain (22Blencowe B.J. Trends Biochem. Sci. 2000; 25: 106-110Abstract Full Text Full Text PDF PubMed Scopus (534) Google Scholar, 23Graveley B.R. RNA (N. Y.). 2000; 6: 1197-1211Crossref PubMed Scopus (878) Google Scholar). The dsx ESE, designated dsxRE, contains nearly identical of a 13-nucleotide repeat K.C. Baker B.S. Cell. 1989; Full Text PDF PubMed Scopus Google Scholar, T. Cell. Full Text PDF PubMed Scopus Google Scholar, Baker B.S. Genes Dev. 5: PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, M. T. 1992; PubMed Scopus Google Scholar, M. T. Cell. Full Text PDF PubMed Scopus Google Scholar, M. T. Genes Dev. 1994; 8: PubMed Scopus Google that a binding site for the of a splicing enhancer TRA, TRA2, and an SR protein T. Genes Dev. 1996; 10: PubMed Scopus (198) Google Scholar). ESEs in activate 3′-splice sites that contain the site of U2 auxiliary factor has that enhancer on ESEs recruit to a 3′-splice site RNA (N. Y.). 1995; 1: Google Scholar, T. Genes Dev. 1996; 10: PubMed Scopus Google Scholar, B.R. T. RNA (N. Y.). 2001; 7: PubMed Scopus Google Scholar). alternative and model that ESEs a the splicing (22Blencowe B.J. Trends Biochem. Sci. 2000; 25: 106-110Abstract Full Text Full Text PDF PubMed Scopus (534) Google Scholar), that in the of the ESEs recruit spliceosomal to the regulated 3′-splice site or has about the mechanisms of 3′-splice site the mechanisms of enhancer-dependent 5′-splice site recognition are has that the SR protein the of to the 5′-splice site of Manley J.L. Nature. 1994; PubMed Scopus Google Scholar, J. C. Manley J.L. 1995; PubMed Scopus Google Scholar, Manley J.L. Sci. A. 1994; PubMed Scopus Google Scholar). However, has established how binding to the 5′-splice site. have examples of alternative 5′-splice site regulation A. A. Baker B.S. J.C. B.J. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, Mol. Cell. Biol. 1998; PubMed Scopus Google Scholar, Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar, M. J. Mol. Cell. Biol. 1999; 19: PubMed Scopus Google Scholar, J. B. 1999; PubMed Scopus Google Scholar, J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). of the are on the identification of the that regulate alternative 5′-splice site have provided this for alternative 5′-splice site choice in the Drosophila fruitless (fru) gene. The study of fru alternative splicing an to on the mechanisms that 5′-splice site fru is in of the in the system J.C. 1994; PubMed Scopus Google Scholar, B.J. A. Baker B.S. J.C. Dev. Genet. 1994; PubMed Scopus Google Scholar). of fru demonstrated that sex-specific alternative splicing of the fru pre-mRNA the of male courtship A. A. Baker B.S. J.C. B.J. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, Sci. A. 1996; PubMed Scopus Google Scholar, J. 2002; PubMed Scopus (98) Google Scholar). dsx, fru is alternatively spliced in a sex-specific that requires TRA and TRA2 to from the to the female-specific A. A. Baker B.S. J.C. B.J. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, Sci. A. 1996; PubMed Scopus Google Scholar). However, in to dsx, fru alternative splicing the of a female-specific 5′-splice site A. A. Baker B.S. J.C. B.J. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar, Sci. A. 1996; PubMed Scopus Google Scholar). requires an located of the female-specific 5′-splice site Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar). the fru designated fruRE, contains three of 13-nucleotide repeat that regulate the female-specific alternative 3′-splice site in dsx TRA and TRA2 regulate dsx and fru alternative the of enhancer In of this was that the fruRE is of the using heterologous in Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar). the dsx enhancer an alternative 3′-splice the fru enhancer an alternative 5′-splice of 13-nucleotide repeat in dsx and in a recognition of is by spliceosomal Curr. Opin. Dev. 1996; 6: PubMed Scopus Google Scholar). to the 5′-splice site by a of and interactions M. Nature. 2002; PubMed Scopus Google Scholar, M. J. RNA (N. Y.). 2002; 8: PubMed Scopus Google Scholar). The 3′-splice site is by The of 5′- or 3′-splice sites requires the of a different of splicing to have demonstrated that only one spliceosomal T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar). However, the in which the alternative splicing of the fru pre-mRNA is regulated that the dsx and fru ESEs recruit spliceosomal components to the adjacent was using an in vitro splicing system that an of the splicing enhancer that the recognition of the fru female-specific 5′-splice site. Mutational analysis demonstrated that one of the 13-nucleotide repeat in the fruRE is sufficient to activate the regulated female-specific splice site. As was demonstrated for dsx, the fruRE can be replaced by a short element encompassing tandem 13-nucleotide repeat elements, by characterized heterologous and by artificially tethering a splicing domain to the pre-mRNA. experiments demonstrated that SR proteins facilitate 5′-splice site activation. These experiments that the fruRE and function similarly in activating regulated 5′- and 3′-splice and suggest that the fru and dsx are of recruiting that contain multiple spliceosomal components required for the initial recognition of 5′- and 3′-splice sites. the in vitro splicing two from from Baker B.S. Mol. Cell. Biol. 1998; PubMed Google were the sites of a that contains the and an the female-specific 5′-splice site and the splicing was from by of and by and are of In all the 13-nucleotide repeat have from to a was repeat in and were used in a the site and an The were and were the The fru used were and The splice the was by in the of The used for were and The contains male- and female-specific 5′-splice but the 5′-splice site. an the fru exonic and 5′-splice site was by using Baker B.S. Mol. Cell. Biol. 1998; PubMed Google the The used for were and The was and the fru exonic and 5′-splice site from was of a 13-nucleotide repeat element to The only 13-nucleotide repeat element in this has for the In two 13-nucleotide repeat the three 13-nucleotide repeat within the a for was the site of that contains two tandem 13-nucleotide repeat of the female-specific 5′-splice site. The pre-mRNA was by using the a and the and the fru The from this was and and B.R. RNA (N. Y.). 2000; 6: 1197-1211Crossref PubMed Scopus (878) Google and The of all were by the of all were to the RNA transcription were RNA The was and RNA were on a and In for in vitro splicing were nuclear PubMed Scopus Google Scholar), of and for were in the or of were for were and to were and using analysis spliced is spliced spliced The was for the of and a The of the female-specific spliced was by the female-specific spliced in the of TRA/TRA2 by the female-specific spliced in the of of and splice site was by the of female-specific spliced to spliced in experiments were essentially that was used of nuclear were of the SR protein In vitro splicing using the proteins were using nuclear B.R. T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar), that the were for were three experiments were within and proteins were B.R. T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar). The of recombinant TRA and TRA2 was to M. T. 1992; PubMed Scopus Google Scholar). In of fru for dsx, the products of the sex determination genes and fru splicing from the to the female-specific the of an that contains 13-nucleotide repeat A. A. Baker B.S. J.C. B.J. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar). However, the dsx enhancer an alternative 3′-splice the fru enhancer an alternative 5′-splice site. investigate the mechanisms of this an in vitro splicing system was established in which recombinant TRA/TRA2 could activate the female-specific 5′-splice site of fru. to the to the mechanisms of enhancer-dependent 3′-splice site in dsx, this on spliceosomal from nuclear the recombinant splicing TRA and TRA2 M. T. 1992; PubMed Scopus Google Scholar). two pre-mRNA and were Both the female-specific 5′-splice an region that contains all three 13-nucleotide repeat to the fruRE, and the The of the was from of to or As in in the of TRA and TRA2, the female-specific 5′-splice site of and was and However, the of TRA and TRA2 to the splicing the female-specific 5′-splice site in pre-mRNA and In to the female-specific splicing splicing to an 5′-splice site located within the fruRE and However, splicing was of the of TRA and The of the female-specific and in were established by and of the experiments was to be within the of splice site a of experiments were As demonstrated in of TRA/TRA2 in of the female-specific 5′-splice site. of the female-specific 5′-splice site was only These that TRA and TRA2 5′-splice site choice. of the in the of the binding characteristic of of These the for dsx T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar), for the that the and fruRE splicing of splicing TRA to of the female-specific splice site The dsx pre-mRNA was used a control to the of the recombinant proteins to the of splice site in the dsx and fru analysis splicing the and dsx However, the of pre-mRNA splicing was to be results that fru female-specific 5′-splice site can be in vitro using nuclear that are the Drosophila recombinant splicing TRA and of to Female-specific study the of repeat a of were in the or of of TRA/TRA2 The and were from by the of 13-nucleotide repeat element in In the of the female-specific 5′-splice site was in of However, in the of the female-specific 5′-splice site was for pre-mRNA one 13-nucleotide repeat element was in the of female-specific of which repeat was and TRA and TRA2 activate female-specific splicing of the in which all three 13-nucleotide have that one repeat is for splicing. the in the of the female-specific spliced for the TRA/TRA2 was can be that the of a single repeat is and sufficient for of the female-specific 5′-splice site. We conclude that the 13-nucleotide repeat are the only splicing that to the of the fru female-specific 5′-splice site. of the fru Female-specific TRA is only in R.T. Belote J.M. McKeown M. Cell. Full Text PDF PubMed Scopus Google Scholar), a of regulation is that the female-specific 5′-splice site is and requires ESEs for Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar). in male in which TRA is the splicing the splice site. In of this the for the and female-specific 5′-splice site are and the 5′-splice site that the splice site be the by the female-specific splice site and the splice site. However, in vitro splicing of that the 5′-splice site of the female-specific splice in the and repeat was and in the of fru, splice site splice site on a T. The RNA Scholar). of the female-specific spliced the spliced that the splicing was and of TRA/TRA2 of the of female-specific splice site choice to splice site choice by investigate regulation of the female-specific 5′-splice site from splice the 5′-splice site was by of the splice site in of regulation by TRA/TRA2 showed of female-specific splice site in the and of TRA/TRA2 and of nuclear These results that of the fru female-specific 5′-splice site requires the of 5′-splice sites. the fru female-specific 5′-splice site a binding site for spliceosomal recognition of the female-specific 5′-splice site by the in the of 5′-splice sites. alternative 5′-splice site choice in the fru pre-mRNA is in by the of splice sites. ESEs the tandem 13-nucleotide repeat have to be sufficient to activate the 3′-splice site in dsx T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar, Sci. A. 1992; PubMed Scopus Google or to to the regulated 3′-splice site M. T. Genes Dev. 1994; 8: PubMed Scopus Google Scholar, T. Genes Dev. 1995; PubMed Scopus Google Scholar). In ESEs have to activate the female-specific 3′-splice site of dsx Mol. Genet. 2000; PubMed Google and ESEs can for the fruRE, two different that the male- and female-specific 5′-splice sites. As in the fruRE was replaced in the of male- and female-specific 5′-splice sites two tandem 13-nucleotide repeat elements, or an the characterized dsx purine-rich element and a enhancer element from in vitro experiments T. Mol. Cell. Biol. 1999; 19: PubMed Scopus Google Scholar). As a which contains a single repeat element. These ESEs were of the regulated 5′-splice site to by SR proteins in nuclear As 5′-splice site was by the splicing of in the of TRA and TRA2 of the fruRE tandem 13-nucleotide or a and the female-specific 5′-splice site and analysis that the of to splicing to and for and the pre-mRNA. the in is in the splicing machinery to the female-specific splice site the in of the female-specific splice site is SR splicing in SR As in the of the recombinant SR protein which the 13-nucleotide repeat J. experiments in a We conclude that heterologous ESEs can for the As demonstrated for 3′-splice the of the female-specific 5′-splice site in fru can be by one of the SR protein RS in to the fru to dsx, TRA and TRA2 the fruRE, and heterologous ESEs by SR proteins can activate the fru female-specific 5′-splice site in has that proteins the protein to a human RS domain can activate the dsx female-specific 3′-splice site artificially to the pre-mRNA B.R. T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar). the proteins can for the dsx the is for the fru ESE, in which the fru enhancer has replaced by a single site pre-mRNA was in nuclear in the or of of a of proteins The pre-mRNA was spliced in the of protein and in the of the protein an RS domain In contrast, the of of three different proteins a RS domain or splicing of the pre-mRNA results were the proteins on the pre-mRNA The of protein was in the activator of which was a of analysis that the of activator was on of the two that the RS domains within enhancer be involved in of interactions to activate 5′- or 3′-splice sites. The of the dsx 3′-splice site has an model system to study the mechanisms of enhancer-dependent 3′-splice site activation. analysis of the regulation of fru alternative splicing an for the regulation of enhancer-dependent alternative 5′-splice site choice. the and of the fruRE and is Both ESEs of 13-nucleotide repeat that are a of untranslated However, the the repeat element and the regulated splice site is only the enhancer and the splice site in fru in As for dsx, heterologous ESEs that function in the of TRA and TRA2 can for the In demonstrated that the fruRE could activate heterologous 5′- and 3′-splice sites Baker B.S. Mol. Cell. Biol. 1998; PubMed Google Scholar). the only the of the and fruRE to be the in which multiple repeat splice site activation. that only one repeat is and sufficient to activate female-specific splicing of the fru pre-mRNA from the in dsx, splicing is to the of repeat T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar). These that multiple repeat are to spliceosomal recognition of the female-specific 5′-splice site. However, that multiple the that is by a single repeat element in the of the splicing machinery to the female-specific 5′-splice site in fru from splicing repeat element could be sufficient to the However, the use of a different pre-mRNA in the splicing an alternative for this the dsx all fru in contain a splice site. As has is that the of the splice site small in splice site J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). of all three repeat to the of 5′-splice site activation. These results are in Baker B.S. Mol. Cell. Biol. 1998; PubMed Google and that the 13-nucleotide repeat are the only that to female-specific 5′-splice site in fru. In the of the repeat the of and the of splice site are fru and of the enhancer in fru and dsx is in for fru and for dsx T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar). These that the enhancer on of the is identical in to the enhancer on of the is that the of TRA and TRA2 the of three enhancer TRA, TRA2, and an SR on the fruRE, identical to those that have in for the T. Genes Dev. 1996; 10: PubMed Scopus (198) Google Scholar). SR the Female-specific experiments that heterologous ESEs can the These ESEs were in female-specific splice site only in the of a 5′-splice site but in splicing As from the and of the the of the fruRE splice site of In the SR protein which is known to the 13-nucleotide repeat was sufficient to activate the female-specific 5′-splice site. different SR proteins function similarly 5′-splice site used an that artificially an RS domain to the pre-mRNA of the fru female-specific 5′-splice site using the As was for the dsx pre-mRNA B.R. T. Mol. Cell. 1998; 1: Full Text Full Text PDF PubMed Scopus Google Scholar), the proteins could for the fru splicing enhancer The that the of three different RS domains was for the dsx and fru that the RS domains within splicing enhancer involved in activating 5′- or 3′-splice sites be involved in of protein These enhancer the proteins different splicing that have protein interaction of the to enhancer-dependent of 3′-splice is to suggest that the fru splicing enhancer the of the splicing machinery the regulated fru female-specific 5′-splice site. is established that and 5′-splice sites are by different components of the splicing machinery Krainer A.R. mRNA Scholar). is that the identical TRA and TRA2 enhancer on the and fruRE recruit different and different from the domain of TRA2, one of the protein components of the enhancer T. Genes Dev. 1996; 10: PubMed Scopus (198) Google Scholar). TRA2 contains two RS domains, one on the and the on the T. Cell. 1994; Full Text PDF PubMed Scopus Google Scholar). is that of the RS domains is for the of to the 5′- or 3′-splice site In RS domains could be located on of TRA2, However, the that the fruRE can be replaced by SR proteins or by proteins that have RS domain for this alternative model the of splicing that interactions the enhancer that the 5′-splice site and components of the splicing machinery this is to all heterologous ESEs the female-specific that the factor RS domain In all proteins 5′- and 3′-splice sites to of the that dsx and fru alternative splicing demonstrated the of ESEs on regulated 5′- and 3′-splice sites. These could that splicing enhancers the mechanisms to or 5′-splice site an of the a model in which the and fruRE recruit identical components to splice but to the regulated exon the that ESEs and 5′-splice site recognition B.J. RNA (N. Y.). 2002; 8: PubMed Scopus Google Scholar), components be the of a to the one in Lee J. Mol. Cell. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, Mol. Cell. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). The the components required for initial recognition of the and 5′-splice sites. the enhancer a the splicing (22Blencowe B.J. Trends Biochem. Sci. 2000; 25: 106-110Abstract Full Text Full Text PDF PubMed Scopus (534) Google Scholar), that a for the of the is to the regulated 5′-splice site and to determine the interactions by which SR splicing enhancer activate regulated splice sites. and of this have in a of the analysis in that the and contain the within the this and were the in vitro splicing experiments in were three The results the were an of the analysis of the was in of the female-specific 5′-splice site was for in the of TRA and TRA2 all in and The of TRA and TRA2 female-specific 5′-splice site only for but for and to the was to female-specific splice site in the of TRA and TRA2 and splice site on the of one 13-nucleotide repeat element. splice site choice was for and and the experiments the of the analysis in the of the study in the The experiments the of study that one repeat element is sufficient to female-specific 5′-splice site However, the the that repeat element is in this the suggest that and in female-specific splice site to be on activating the 5′-splice site. These are the The 13-nucleotide splicing enhancer and activate the splice repeat is for the of the female-specific 5′-splice site. is that the of splicing enhancer to splice sites the of exon The the that the 13-nucleotide repeat are the only that of the female-specific splice the that and the of a splicing The that female-specific splicing in the of TRA and TRA2 is the from dsx that 13-nucleotide repeat have are within to the regulated splice site and splicing of We and of the for on the We Baker for fru

References

50